Pyrophosphoric Acid

Pyrophosphoric Acid

SCHEMBL668584

Nc1ncnc2c1ncn2[C@]1(P(=O)(O)O)O[C@H](CO)[C@@H](O)[C@H]1O.O=P(O)(O)OP(=O)(O)O

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 3/20 0.52
P2RY2 P41231 4/20 0.48
P2RY1 P47900 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
SRC P12931 2/20 0.46
DNPH1 O43598 1/20 0.46
PRKAB2 O43741 1/20 0.46
TRPM2 O94759 1/20 0.46
LDHA P00338 1/20 0.46
ADRB2 P07550 1/20 0.46
FBP1 P09467 1/20 0.46
PRKAG1 P54619 1/20 0.46
PRKAA2 P54646 1/20 0.46
PDE4D Q08499 1/20 0.46
KCNH2 Q12809 1/20 0.46
PRKAA1 Q13131 1/20 0.46
PDE3A Q14432 1/20 0.46
TAS1R3 Q7RTX0 1/20 0.46
TAS1R1 Q7RTX1 1/20 0.46
P2RY11 Q96G91 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL199259 0.95 ADORA1 (0.51) ADORA1P2RY2P2RY1SMN1; SMN2SRC
Phosphoric Acid SCHEMBL216583 0.94 ADORA1 (0.50) ADORA1P2RY2P2RY1SMN1; SMN2SRC
SCHEMBL15665475 0.92 ADORA1 (0.52) ADORA1P2RY2P2RY1SMN1; SMN2SRC
SCHEMBL668586 0.88 P2RX1 (0.59) ADORA1P2RY2P2RY1SMN1; SMN2SRC
SCHEMBL214972 0.87 P2RY1 (0.59) ADORA1P2RY2P2RY1SMN1; SMN2SRC
SCHEMBL8572697 0.83 ADORA1 (0.38) ADORA1SMN1; SMN2ADORA3ADORA2ADPP4
Adenosine SCHEMBL14783412 0.83 P2RY2 (0.65) ADORA1P2RY2P2RY1SMN1; SMN2SRC
SCHEMBL13738525 0.83 ADORA1 (0.38) ADORA1SMN1; SMN2ADORA3ADORA2ADPP4
SCHEMBL27971039 0.83 FDPS (0.42) ADORA1SMN1; SMN2ADORA3ADORA2ADPP4
Pyrophosphoric Acid SCHEMBL18486727 0.82 ADORA1 (0.48) ADORA1P2RY2P2RY1SMN1; SMN2SRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023230560-A1 TREATMENT OF ORGANIC ACIDEMIAS OR PANTOTHENATE KINASE ASSOCIATED NEURODEGENERATION WITH MODULATORS OF PANTOTHENATE KINASES COA THERAPEUTICS, INC. (US) 2023-11-30 WO disclosed
US-10208270-B2 Acyltransferases and uses thereof in fatty acid production BASF PLANT SCIENCE COMPANY GMBH (DE) 2019-02-19 US disclosed
EP-2585603-B1 ACYLTRANSFERASES AND USES THEROF IN FATTY ACID PRODUCTION BASF PLANT SCIENCE CO GMBH (DE) 2017-12-20 EP disclosed
US-20160272951-A1 ACYLTRANSFERASES AND USES THEREOF IN FATTY ACID PRODUCTION BASF PLANT SCIENCE COMPANY GMBH (DE) 2016-09-22 US disclosed
US-9388437-B2 Acyltransferases and uses thereof in fatty acid production BASF PLANT SCIENCE COMPANY GMBH (DE) 2016-07-12 US disclosed
EP-2585603-A1 ACYLTRANSFERASES AND USES THEROF IN FATTY ACID PRODUCTION BASF Plant Science Company GmbH (DE) 2013-05-01 EP disclosed
US-20130097733-A1 Acyltransferases and Uses Thereof in Fatty Acid Production BASF PLANT SCIENCE COMPANY GMBH (DE) 2013-04-18 US disclosed
WO-2012024189-A2 COMPOSITIONS AND METHODS FOR DETERMINING PREDISPOSITION TO DEVELOPING METABOLIC SYNDROME THE J. DAVID GLADSTONE INSTITUTES (US) 2012-02-23 WO disclosed
WO-2011161093-A1 ACYLTRANSFERASES AND USES THEROF IN FATTY ACID PRODUCTION BASF PLANT SCIENCE COMPANY GMBH (DE) 2011-12-29 WO disclosed